Search the web
Welcome, Guest
[Sign Out, My Account]

Friday, November 28 2014 8:36am ET - U.S. Markets open in 54 minutes.
Industry Center
Industry Center > > Human Genome Sciences, Inc. Company Profile
More On This Industry
· Summary
· News
· Leaders & Laggards
· Company Index
·Industry Browser
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Need more? Get unbiased, in-depth information on public and private companies worldwide.
Human Genome Sciences, Inc. Company Profile
Human Genome Sciences (HGS) starts at the molecular level for good health. Using its expertise in human genetics, the biopharmaceutical discovery and development firm is working on therapies for infectious and autoimmune diseases, cardiovascular disease, and cancer. In 2011 lead candidate Benlysta gained FDA approval to treat systemic lupus and has since been extended into international markets. The company's only other commercial product is raxibacumab, an antibody treatment for inhaled anthrax. In addition, the company provides contract research and manufacturing services to other biotechs. Benlysta was developed through a partnership with GlaxoSmithKline (GSK). In 2012 HGS was acquired by GSK.
Headlines for Human Genome Sciences, Inc.
Never-before-seen human genome variations uncovered
- Tue Nov 11
How malaria-carrying species of mosquitoes are related to each other
- Fri 3:05 am ET
Will Purr for Treats: How Cats Became Domesticated
- Tue Nov 11
Fondness for treats may have helped cats become pets
- Fri Nov 14
Cats cosy up for rewards: study
- Mon Nov 10
New Tool Could Help Reshape The Limits Of Synthetic Biology
- Mon Nov 3
Kalorama Announces List of "Proteomics Pioneers"
- Mon Nov 3
Contact Information
Address: 14200 Shady Grove Rd.
Rockville, MD 20850-7464
Financial Highlights
Fiscal Year End:December
Key People
President, CEO, and Director: H. Thomas (Tom) Watkins
EVP and CFO: David P. Southwell
EVP and Chief Commercial Officer: Barry A. Labinger
Industry Information
Top Competitors
Biogen Idec Inc. (biib)
Emergent BioSolutions Inc. (ebs)
Genentech, Inc.

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?